Bottom line
Neurodegenerative disease is not "getting confused because you got old." It is a group of diseases that can be managed decades ahead. Parkinson's disease and Alzheimer's disease, among others, have already begun 15 to 20 years before symptoms appear 8.
The line in the title, that what helps the heart often helps the brain, is not rhetoric. Stanford neurosurgeon Steinberg said it plainly in an interview: "In general, the things that are good for the heart are good for the brain" 5.
The brain is only about 2% of body weight, and it consumes about 20% of the oxygen and takes about 15% of the blood flow. That dependence on the vascular system is what locks the two together 5.
One public review shows that small-vessel disease in the brain is involved in about half of dementia cases worldwide. Risk factors from "the heart's side" — high blood pressure, diabetes, obesity — are at the same time rewriting the brain's supply lines 7.
The evidence end has surprises too. A randomized trial of tighter blood-pressure control significantly reduced mild cognitive impairment. A combined, multidomain lifestyle intervention slowed the slide in cognitive scores after two years 1110.
What it is
Neurodegenerative disease is a large class of illness in which nerve cells are gradually lost and can no longer work effectively. The most common are Alzheimer's disease, where memory and thinking are affected first, and Parkinson's disease, where movement control is affected first.
Dementia is one of their consequences: cognitive ability declines far enough to interfere with daily life. The World Health Organization's 2021 estimate is that about 57 million people worldwide are living with it, and that the economic burden in 2019 was about $1.3 trillion 12.
This family of diseases has a feature: the pathology starts accumulating many years before symptoms. One topic page turns that into a reminder. Waiting until old age to worry is too late. Structures such as the hippocampus are especially vulnerable 8.
"Small-vessel disease" is the key to this piece. Once the dense net of small vessels in the brain works poorly, the blood-brain barrier — the brain's "doorkeeper" — leaks, white matter is injured, supply falls, and cognition is affected in turn 7.
APOE is another keyword. It is the apolipoprotein that carries cholesterol in the brain, encoded by the APOE gene. The APOE4 form clearly raises the risk of Alzheimer's disease. The brain's cholesterol is made and used on site, relatively independent of the set in the blood 3.
BDNF, brain-derived neurotrophic factor, can be understood as a "nourishment signal" for the brain. During exercise, both muscle and brain make more of it. It supports neuroplasticity, the brain's ability to rewire and to learn something new 9.
Why it matters
First, the scale. Fifty-seven million people worldwide, and the number is still rising with aging. More than six in ten live in low- and middle-income countries 12.
Second, the time window. A latent period of 15 to 20 years before symptoms means that vascular and metabolic status in midlife is the bill the brain will pay decades later 8.
Third, a large share can be changed. Risk factors the World Health Organization lists include high blood pressure, obesity, diabetes, hearing loss, depression, lack of activity, smoking, social isolation, low education, and air pollution. Most of those can be acted on 12.
Fourth, women's situation is different. In an interview, Devi specifically discussed why women have a higher risk of Alzheimer's disease and what the brain's changes at menopause mean. That is also why screening and care have to be individualized 4.
The figure that small-vessel disease is involved in about half of dementia cases worldwide turns "look after the vessels" from a private matter of cardiology into the main line of brain health 7.
The topic page offers a few matching observations along the way. Aerobic exercise is associated with a smaller burden of small-vessel disease. People with more visceral fat have heavier imaging markers. People with high blood pressure have both a heavier burden and a higher risk of cognitive impairment. The direction is consistent: move, manage waist size, manage blood pressure 7.
Different perspectives
Main positions
One frame is to act on causes early, and keep at it. In a conversation with lipid expert Davidson, the talk keeps returning to one theme: the knowledge for preventing cardiovascular disease has been around for a long time. The gap is whether it is put to use starting at age thirty 2.
On the episode Davidson says, "we have the knowledge to prevent heart disease now." The critical difference is whether the work starts earlier. That sentence is used to support a core claim: for a person with high apoB, pressing the risk down earlier benefits both brain and heart 2.
The same episode also covers the genetics of APOE4 and CETP, the brain's independent cholesterol metabolism, and why statins do not cause Alzheimer's disease 2.
On the episode with lipidology expert Dayspring, this "brain lipidology" is told in more detail. The brain makes cholesterol with its own apoE lipoproteins. It does not depend on low-density-lipoprotein particles in the blood, so lowering LDL does not empty the brain's cholesterol 3.
On the clinical side, geriatric neurologist Devi discusses the dementia spectrum. Dementia is not a single disease. Early detection and individualized multimodal care are changing the landscape of care 4. These conversations sit together as a long-running public line on cognitive health and neurodegenerative-disease prevention 1.
The Steinberg episode turns the relationship of heart and brain into a physiology lesson: 2% of body weight, 15% of blood flow, 20% of oxygen use. Many risk factors for stroke are the same batch as for heart disease. Too little exercise, obesity, and high blood pressure lead both toward stroke and toward a heart attack 5.
There is also a full episode on exercise and the brain: how different kinds of exercise — resistance training, aerobic work of different lengths — improve learning and memory in the moment and over the long run, and how the benefits of regular exercise compound with time 6.
The shared ground of the two episodes: brain health is not the brain's private business. It hangs on blood flow, metabolism, and physical activity 56.
One side of the record lays out three directions.
The small-vessel-disease topic page talks the mechanism through: endothelial dysfunction, a leaking blood-brain barrier, white-matter hyperintensities, impaired waste clearance by the glymphatic system, and the epidemiology that "small-vessel disease is involved in about half of dementia worldwide" 7.
The topic page on polyphenols and brain aging ties brain aging to glucose metabolism. Foods rich in anthocyanins, such as blueberries, have shown movement in the favorable direction on both cognitive markers and glucose markers in studies. Even glucose in the high end of the reference range is associated with hippocampal shrinkage, which is why Alzheimer's disease is sometimes called "type 3 diabetes" 8.
The topic page on exercise and cognition focuses on BDNF. High-intensity exercise raises it in particular, and in the research the gain in long-term memory from a single bout of exercise can last as long as two months 9.
Where views agree and differ
Where the views line up closely:
- Vascular and metabolic health are the foundation of brain health. The same batch of risk factors works at both ends 578.
- Intervention has to start early. Midlife, or earlier, is when the compounding begins 82.
- Exercise is the single lever with the most systematic evidence, and resistance work and aerobic work have different jobs 69.
Where the emphasis differs:
- One handle is lipids and the drug path (press apoB down early, and the possibility of newer drugs such as obicetrapib). The color is more expert experience, and the randomized evidence is still on the way 2.
- Another emphasizes a behavioral toolbox: how to pair resistance training with aerobic work of different lengths, explaining the mechanism so a person can assemble it, with the benefit accumulating over time 6.
- Another emphasizes micronutrients and food components (polyphenols, glucose management). Much of that evidence is observational, and trial evidence is scarce 8.
- On "cognitive training" interventions, the FINGER trial supports a multidomain combination 10. Whether brain-training games alone can independently hold off cognitive decline has much weaker evidence.
PearHealth's synthesis
"What helps the heart often helps the brain" is taken as the skeleton of this piece, because it has a clear physiological basis (dependence on blood supply) and direct support from two randomized trials (tighter blood-pressure control, and a multidomain intervention) 51110.
What is adopted: blood-pressure management, exercise, glucose and weight management, not smoking, hearing, and social participation. All of these appear on the World Health Organization's list of risk factors, and they overlap the language of these public accounts 12.
What is held back: the value of APOE4 testing for an ordinary person is still unclear. Existing material uses genetic testing as a tool for identifying people at higher risk, and it does not discuss whether knowing the genotype changes behavior. Newer drug paths are not mature either. Research on polyphenol-rich foods is mostly observational and short trials. The direction is hopeful, and it does not land on a number 28.
A particular emphasis: assessment of cognitive symptoms belongs with a clinician. Forgetting names and slow word-finding are mostly ordinary aging. What situation merits a referral to a memory clinic is a professional judgment, not a self-diagnosis 4.
We do not sell cognitive supplements, and any product that claims to "reverse" cognitive decline is worth one more question about the grade of its evidence.
How strong is the evidence
The firmest layer is randomized controlled trials.
- SPRINT MIND: more than 9,000 adults aged 50 and older with high blood pressure were randomized to intensive or standard blood-pressure control. Mild cognitive impairment fell significantly. For the endpoint of "probable dementia," the hazard ratio was 0.83 (confidence interval 0.67 to 1.04, not significant). The combined incidence of the two was 20.2 versus 24.1 per 1,000 person-years. It supports the direction "lowering blood pressure protects the brain." A single endpoint was affected by the trial stopping early 11.
- FINGER: 1,260 older adults at risk were randomized to a multidomain intervention (diet, exercise, cognitive training, and vascular-risk monitoring) or to a control. Over two years, the difference in annual change on a composite cognitive score was 0.022 (p = 0.030). The effect is small. The direction is consistent, and the scale is substantial 10.
Medium firmness: the link between small-vessel disease and dementia comes from imaging and cohort studies. "About half of cases" is an epidemiologic attribution, not an experimental conclusion 7.
The weaker layer: the links between glucose in the high range and hippocampal shrinkage, and between polyphenols and cognition, are mainly observational and small-sample trials. Specific claims in the public conversations (lowering apoB early, particular foods) are reasoning from experience and mechanism, and they need trials ahead of them to fill in 82.
What you can do
One workable direction: treat this list as the brain-health column of a heart list. Most of the actions benefit both sides at once.
Directions many people take:
- Exercise regularly, and schedule both aerobic work and resistance work. The evidence on BDNF and on brain blood flow is the most systematic 69.
- Manage blood pressure, glucose, and lipids under a clinician's direction. Numeric targets stay with the clinician. Do not adjust medicines on your own 1112.
- Treat sleep as infrastructure for brain health. Regular exercise often comes with better sleep, and sleep helps store what was newly learned 9.
- Keep up social life and hearing. Hearing loss and social isolation are both on the World Health Organization's list. Using a hearing aid is not a small matter 12.
- Start in midlife. Do not wait for symptoms. The pathology starts 15 to 20 years ahead, and an earlier pull on the lever lasts longer 8.
- Shift diet toward polyphenol-rich foods (berries, tea, vegetables) as part of overall diet quality, not as a medicine 8.
Questions worth raising with a clinician:
- Given a family history of dementia, does my blood-pressure target need to be tighter 11?
- Is my APOE4 worth testing? If I test, what would change 2?
- Could the statin I take affect cognition? The line in these two episodes: statins do not cause Alzheimer's disease, and lowering LDL does not empty the cholesterol the brain makes for itself. That is not the same as a conclusion about every effect on cognition 32.
- My mother has been diagnosed with dementia. How is my screening and follow-up arranged 4?
Common misconceptions
Misconception one: taking a statin to lower cholesterol will damage the brain. In practice, the brain's cholesterol is synthesized on site and does not depend on transport in the blood. Lowering LDL does not empty it. The expert conversations explicitly discuss why statins do not cause Alzheimer's disease 32.
Misconception two: forgetting names, or being unable to find a word, is the start of dementia. In practice, Devi's clinical view is that the great majority of these are ordinary aging. What is actually worth noticing is a patterned change that interferes with daily life 4.
Misconception three: the brain can wait until retirement. In practice, neurodegenerative change has already begun 15 to 20 years before symptoms. Midlife is the window 8.
Misconception four: a positive APOE4 is a death sentence. In practice, the genotype raises risk. It is not certainty. Beyond risk stratification, management of the changeable factors applies to people at high risk as well 212.
Misconception five: protecting the brain means doing more brain-training games, and that is enough. In practice, physical exercise has a more systematic evidence chain for cognition (BDNF, brain blood flow, multiple trials). Brain-training games can be one part of a combination. They are not a substitute 96.
How it connects to your blood work
No blood test directly predicts who will develop dementia. The vascular and metabolic items are the laboratory end of this topic.
- Homocysteine (homocysteine): a long-studied population association with cognitive risk, also affected by folate and vitamin B12 status.
- Glycated hemoglobin (hba1c) and fasting glucose (fasting-glucose): longer-term glucose level is tied to the pace of brain aging. When glucose sits in the high end of the reference range, the hippocampus is more vulnerable 8.
- Apolipoprotein B (apob) and LDL cholesterol (ldl-c): central markers of vascular risk, the laboratory entrance to "what helps the heart often helps the brain" 5.
- Vitamin B12 (vitamin-b12): a deficiency can produce symptoms that resemble cognitive decline, and it is a correctable direction to check.
- High-sensitivity C-reactive protein (hs-crp): an overall signal of low-grade inflammation, a side witness to vascular health.